Rituximab or a second anti-TNF therapy for rheumatoid arthritis patients who have failed their first anti-TNF? Comparative analysis from the British Society for Rheumatology Biologics Register
Arthritis Care & Research ,

Soliman MM et al. – The results suggest that switching to rituximab (RTX) may be of more benefit to switching to an alternative anti–tumour necrosis factor (anti–TNF) therapy after failing the first anti–TNF in Rheumatoid arthritis (RA) patients.

Methods
  • RA patients were registered with the British Society for Rheumatology Biologics Register.
  • Response to treatment six months after switching was assessed using:
    • (1) European League Against Rheumatism (EULAR) criteria
    • (2) improvements in Health Assessment Questionnaire (HAQ) score (0.22 units or more).
  • Regressionanalysis was used to compare EULAR response and improvement in HAQ between the two groups, adjusting for propensity scores.

Results
  • In total, 1328 patients were included in the analysis of EULAR response and 937 patients were included inthe analysis of HAQ score.
  • Six months after switching, 54.8% of patients who switched to RTX were EULAR responders compared to 47.3% of those who switched to a second anti–TNF.
  • 38.4% of RTX patients achieved a clinically important improvement in HAQ compared to 29.6% in anti–TNF patients.
  • After adjustment using propensity scores, patients who switched to RTX were significantly more likely to achieve EULAR response; OR (95% CI) 1.31 (1.02, 1.69) compared to those who switched to an alternative anti–TNF.
  • RTX patients were also significantly more likely to achieve improvements in HAQ; (OR (95% CI) 1.49 (1.07, 2.08).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Medical Student

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Medical Student Articles

Indexed Journals in Medical Student: Academic Medicine, BMC Medical Education, Medical Teachermore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close